KellBenx Obtains $1,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=979927bb-d57c-405c-88f2-af2027a9ade6&Preview=1 -
Date
2/29/2012 -
Company Name
KellBenx -
Mailing Address
3500 Sunrise Highway Building 200 Great River, NY 11739 -
Company Description
KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood. Our focus is to improve women’s healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. -
Website
http://www.kellbenx.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
